| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Wednesday, October 19, 2022 7:08:38 AM
Most investors go off of summaries since they are not new scientists and this is especially true for new investors and potential investors.
Right now here is a top result for NWBO on Google:
https://seekingalpha.com/article/4547170-northwest-biotherapeutics-biopharmas-promising-delinquent
When NWBO does not effectively communicate this is what people read. They’re not coming on here to get both sides.
So if one wants NWBO to get a good image and argue that gas to wait on the journal article then that is an argument one still maker albeit a weaker one with each passing week.
What I am saying is that Adam Feuerstein can and will control the narrative if NWBO management does not prove by deeds that they have learned from the last two major clashes with him (Buzdargate and NYAS).
That is a reasonable point and not even an anti-management point but basically just the fact of the matter.
Right now here is a top result for NWBO on Google:
https://seekingalpha.com/article/4547170-northwest-biotherapeutics-biopharmas-promising-delinquent
When NWBO does not effectively communicate this is what people read. They’re not coming on here to get both sides.
So if one wants NWBO to get a good image and argue that gas to wait on the journal article then that is an argument one still maker albeit a weaker one with each passing week.
What I am saying is that Adam Feuerstein can and will control the narrative if NWBO management does not prove by deeds that they have learned from the last two major clashes with him (Buzdargate and NYAS).
That is a reasonable point and not even an anti-management point but basically just the fact of the matter.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
